Xiaoyong Xiao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Xiaoyong Xiao has a total of 48 co-authors. Here are the top co-authors by number of shared publications:
- Dehong Liu
Department of Emergency Medicine, The First Affiliated Hospital of Shenzhen University, HealthScience Center, Shenzhen Second People’s Hospital, Shenzhen, 518035, China
3 shared publications - Zhe Deng
Department of Emergency Medicine, Shenzhen Second People’s Hospital/the First Affiliated Hospital of Shenzhen University, Shenzhen, China
3 shared publications Xiaohua Xiao
Department of Geriatric Medicine, The First Affiliated Hospital of Shenzhen University, Health Science Center, Shenzhen Second People’s Hospital, Shenzhen, Guangdong, China
2 shared publications- Yu Zhou
Department of Vascular Surgery The First Affiliated Hospital, Sun Yat‐sen University Guangzhou Guangdong China
2 shared publications - Abdelouahab Bellou
Institute of Sciences in Emergency Medicine, Guangdong Academy of Medical Sciences, Guangzhou, China
1 shared publication Beiyou Lin
Department of Cardiology (J.X., B.L., K.W., X.J.), Zhuhai People’s Hospital (Zhuhai Hospital Affiliated With Jinan University), China
1 shared publication
Latest Publications
- Open Access
- 11 May 2026
- Published by Frontiers Media SA in Frontiers in Nutrition
- Vol. 13, 1722116
Weight changes and all-cause mortality in critically ill patients: a multi-center retrospective cohort study
Objective: Body weight changes is a readily available composite metric in critically ill patients that may reflect both fluid balance and nutritional-metabolic status. However, large-scale evidence on its independent association with—and predictive value for—patient-centered outcomes such as mortality remains limited. Methods: This large, multicenter retrospective study used the U.S. eICU Collaborative Research Database. A total of 30,537 adult critically ill patients were included. The primary exposure was weight change rate. Feature selection was performed with the Boruta machine-learning algorithm. Multivariable logistic regression was used to estimate the association between weight change rate and mortality. Non-linear relationships and threshold effects were explored with generalized additive models (GAM) and two-piece linear regression. Discriminative performance was assessed with the area under the receiver operating characteristic curve (AUC). Results: Boruta identified body weight change rate as an important predictor of both ICU and hospital mortality. After multivariable adjustment, each additional percentage of weight gain was associated with a significant increase in ICU mortality (OR 1.04, 95% CI 1.03–1.05) and hospital mortality (OR 1.03, 95% CI 1.03–1.04) (both p < 0.0001). The association between weight change rate and mortality risk was non-linear, with a slope change (threshold effect) occurring at approximately 5% (ICU mortality: 5.14%; hospital mortality: 4.73%). Weight change rate provided superior discrimination compared with static indices such as admission weight, discharge weight, or admission BMI. Conclusion: In this large cohort, the ICU-derived weight change rate is an independent predictor of mortality in critically ill patients and exhibits a non-linear relationship with a threshold effect at approximately 5%. Dynamic monitoring of weight change rate outperforms static anthropometric measures and may serve as a simple yet powerful bedside tool for prognostic assessment.
- 11 May 2026
- Published by Frontiers Media SA in Frontiers in Nutrition
- Vol. 13, 1722116
Open AccessWeight changes and all-cause mortality in critically ill patients: a multi-center retrospective cohort study
Objective: Body weight changes is a readily available composite metric in critically ill patients that may reflect both fluid balance and nutritional-metabolic status. However, large-scale evidence on its independent association with—and predictive value for—patient-centered outcomes such as mortality remains limited. Methods: This large, multicenter retrospective study used the U.S. eICU Collaborative Research Database. A total of 30,537 adult critically ill patients were included. The primary exposure was weight change rate. Feature selection was performed with the Boruta machine-learning algorithm. Multivariable logistic regression was used to estimate the association between weight change rate and mortality. Non-linear relationships and threshold effects were explored with generalized additive models (GAM) and two-piece linear regression. Discriminative performance was assessed with the area under the receiver operating characteristic curve (AUC). Results: Boruta identified body weight change rate as an important predictor of both ICU and hospital mortality. After multivariable adjustment, each additional percentage of weight gain was associated with a significant increase in ICU mortality (OR 1.04, 95% CI 1.03–1.05) and hospital mortality (OR 1.03, 95% CI 1.03–1.04) (both p < 0.0001). The association between weight change rate and mortality risk was non-linear, with a slope change (threshold effect) occurring at approximately 5% (ICU mortality: 5.14%; hospital mortality: 4.73%). Weight change rate provided superior discrimination compared with static indices such as admission weight, discharge weight, or admission BMI. Conclusion: In this large cohort, the ICU-derived weight change rate is an independent predictor of mortality in critically ill patients and exhibits a non-linear relationship with a threshold effect at approximately 5%. Dynamic monitoring of weight change rate outperforms static anthropometric measures and may serve as a simple yet powerful bedside tool for prognostic assessment.
- 29 April 2026
- Published by Bentham Science Publishers Ltd. in Current Medicinal Chemistry
- Vol. 33 (21) , 4447-4469
Identification of PPIA, DPP4, and ITK as Potential Targets of Pterostilbene in Abdominal Aortic Aneurysm: A Network Pharmacology and Molecular Docking Study
Introduction: Pterostilbene is a polyphenolic component that has antioxidant and anti-inflammatory properties, and the current study aims to elucidate its potential therapeutic effects on abdominal aortic aneurysm (AAA). materials and methods: The single-cell sequencing data and transcriptome datasets obtained from the Gene Expression Omnibus (GEO) database were applied to identify the differentially expressed genes (DEGs) in AAA, which were intersected with the predicted targets of Pterostilbene. The overlapping genes were defined as the core genes for functional enrichment analysis and gene set enrichment analysis (GSEA). The binding of the core genes to Pterostilbene was additionally validated in molecular docking. results: The potential target genes associated with Pterostilbene and the DEGs in AAA were identified with varied enriched pathways. 3 core genes were identified as the potential targets of Pterostilbene and the DEGs in AAA, namely, PPIA, DPP4, and ITK, which were significantly correlated with pathways like MTORC1_SIGNALING, IL6_JAK_STAT3_SIGNALING, and INFLAMMATORY_RESPONSE. GSEA indicated that these genes were enriched in pathways related to immune response and oxidative phosphorylation. Furthermore, the differential expression of the 3 core genes was observed, and the results of molecular docking demonstrated the binding affinities of Pterostilbene with the 3 core genes. discussion: This multi-omics study revealed that Pterostilbene may exert its therapeutic effects on AAA by regulating inflammation- and immune-related pathways, providing theoretical support for its further development as a therapeutic drug. conclusion: Pterostilbene may exert its therapeutic effects on AAA by modulating inflammation- and immunity-related signaling pathways and targeting the 3 core genes (PPIA, DPP4, and ITK), which warrants further investigation on the therapeutic potential.
- 29 April 2026
- Published by Bentham Science Publishers Ltd. in Current Medicinal Chemistry
- Vol. 33 (21) , 4447-4469
Identification of PPIA, DPP4, and ITK as Potential Targets of Pterostilbene in Abdominal Aortic Aneurysm: A Network Pharmacology and Molecular Docking Study
Introduction: Pterostilbene is a polyphenolic component that has antioxidant and anti-inflammatory properties, and the current study aims to elucidate its potential therapeutic effects on abdominal aortic aneurysm (AAA). materials and methods: The single-cell sequencing data and transcriptome datasets obtained from the Gene Expression Omnibus (GEO) database were applied to identify the differentially expressed genes (DEGs) in AAA, which were intersected with the predicted targets of Pterostilbene. The overlapping genes were defined as the core genes for functional enrichment analysis and gene set enrichment analysis (GSEA). The binding of the core genes to Pterostilbene was additionally validated in molecular docking. results: The potential target genes associated with Pterostilbene and the DEGs in AAA were identified with varied enriched pathways. 3 core genes were identified as the potential targets of Pterostilbene and the DEGs in AAA, namely, PPIA, DPP4, and ITK, which were significantly correlated with pathways like MTORC1_SIGNALING, IL6_JAK_STAT3_SIGNALING, and INFLAMMATORY_RESPONSE. GSEA indicated that these genes were enriched in pathways related to immune response and oxidative phosphorylation. Furthermore, the differential expression of the 3 core genes was observed, and the results of molecular docking demonstrated the binding affinities of Pterostilbene with the 3 core genes. discussion: This multi-omics study revealed that Pterostilbene may exert its therapeutic effects on AAA by regulating inflammation- and immune-related pathways, providing theoretical support for its further development as a therapeutic drug. conclusion: Pterostilbene may exert its therapeutic effects on AAA by modulating inflammation- and immunity-related signaling pathways and targeting the 3 core genes (PPIA, DPP4, and ITK), which warrants further investigation on the therapeutic potential.
- Open Access
- 1 December 2025
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 45 (12) , 2210-2225
Genetic Ablation of miR-146a Induces Abdominal Aortic Aneurysm Formation by Intensifying Inflammatory M1-Like Macrophages Polarization and Vascular Smooth Muscle Cell Phenotypic Switching
BACKGROUND: Abdominal aortic aneurysm (AAA), a pathological dilation of the abdominal aorta, is primarily driven by chronic aortic wall inflammation. The well-established anti-inflammatory microRNA 146a (miR-146a) has been implicated as a key regulator in various chronic inflammatory pathologies. However, its potential functional role in the pathogenesis of AAA remains to be elucidated. METHODS: We constructed Ang II (angiotensin II)–induced and PPE (porcine pancreatic elastase)–induced models in global miR-146a knockout mice, vascular smooth muscle cell (VSMC)–specific miR-146a knockout mice, and macrophage-specific miR-146a knockout mice, respectively, to explore the role of miR-146a in AAA. Western blot, quantitative polymerase chain reaction, and immunohistochemistry were used to detect the levels of aortic proinflammatory markers and VSMC contractile proteins, whereas flow cytometry was used to assess M1/M2–like macrophage polarization. To validate the downstream mechanism, dibenzazepine was intraperitoneally injected to inhibit the Notch1 pathway in rescue experiments. RESULTS: In the Ang II–induced and PPE-induced model, global knockout of miR-146a promoted AAA development, increased maximal aortic diameter, exacerbated medial elastin degradation, and upregulated aortic proinflammatory markers (COX2 [cyclooxygenase 2], MMP [matrix metalloproteinase] 2, MMP9, and CCL2 [chemokine (C-C motif) ligand 2]). Flow cytometry analysis revealed that global miR-146a deficiency also induced macrophage polarization toward the inflammatory M1 phenotype. Conditional deletion of miR-146a in VSMCs and macrophages largely replicated AAA formation and proinflammatory effects. Furthermore, AAV9 (adeno-associated virus)-mediated miR-146a knockdown significantly reduced VSMC contractile proteins CNN1 (calponin 1), SM22α (smooth muscle 22α), and α-SMA (α-smooth muscle actin) in mouse aortas at 7 days post–Ang II perfusion. Mechanistically, Notch1 antagonist dibenzazepine effectively rescued AAA characteristics and M1 biomarkers while enhancing M2 biomarkers in global miR-146a knockout mice. CONCLUSIONS: The absence of miR-146a potentiates AAA formation by promoting VSMC phenotypic switching, Notch1 signaling–mediated aortic inflammation, and macrophage M1 polarization. Thus, miR-146a plays a critical role in maintaining aortic structural integrity to prevent aneurysmal pathogenesis.
- 1 December 2025
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 45 (12) , 2210-2225
Open AccessGenetic Ablation of miR-146a Induces Abdominal Aortic Aneurysm Formation by Intensifying Inflammatory M1-Like Macrophages Polarization and Vascular Smooth Muscle Cell Phenotypic Switching
BACKGROUND: Abdominal aortic aneurysm (AAA), a pathological dilation of the abdominal aorta, is primarily driven by chronic aortic wall inflammation. The well-established anti-inflammatory microRNA 146a (miR-146a) has been implicated as a key regulator in various chronic inflammatory pathologies. However, its potential functional role in the pathogenesis of AAA remains to be elucidated. METHODS: We constructed Ang II (angiotensin II)–induced and PPE (porcine pancreatic elastase)–induced models in global miR-146a knockout mice, vascular smooth muscle cell (VSMC)–specific miR-146a knockout mice, and macrophage-specific miR-146a knockout mice, respectively, to explore the role of miR-146a in AAA. Western blot, quantitative polymerase chain reaction, and immunohistochemistry were used to detect the levels of aortic proinflammatory markers and VSMC contractile proteins, whereas flow cytometry was used to assess M1/M2–like macrophage polarization. To validate the downstream mechanism, dibenzazepine was intraperitoneally injected to inhibit the Notch1 pathway in rescue experiments. RESULTS: In the Ang II–induced and PPE-induced model, global knockout of miR-146a promoted AAA development, increased maximal aortic diameter, exacerbated medial elastin degradation, and upregulated aortic proinflammatory markers (COX2 [cyclooxygenase 2], MMP [matrix metalloproteinase] 2, MMP9, and CCL2 [chemokine (C-C motif) ligand 2]). Flow cytometry analysis revealed that global miR-146a deficiency also induced macrophage polarization toward the inflammatory M1 phenotype. Conditional deletion of miR-146a in VSMCs and macrophages largely replicated AAA formation and proinflammatory effects. Furthermore, AAV9 (adeno-associated virus)-mediated miR-146a knockdown significantly reduced VSMC contractile proteins CNN1 (calponin 1), SM22α (smooth muscle 22α), and α-SMA (α-smooth muscle actin) in mouse aortas at 7 days post–Ang II perfusion. Mechanistically, Notch1 antagonist dibenzazepine effectively rescued AAA characteristics and M1 biomarkers while enhancing M2 biomarkers in global miR-146a knockout mice. CONCLUSIONS: The absence of miR-146a potentiates AAA formation by promoting VSMC phenotypic switching, Notch1 signaling–mediated aortic inflammation, and macrophage M1 polarization. Thus, miR-146a plays a critical role in maintaining aortic structural integrity to prevent aneurysmal pathogenesis.
- Open Access
- 21 January 2025
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 87 (3) , 1282-1294
Comprehensive analysis the role of cuproptosis related genes in abdominal aortic aneurysm
Immune infiltration plays an important role in the course of abdominal aortic aneurysm (AAA) development, and copper death (cuproptosis) is a new type of programmed cell death recently discovered. Currently, there are no studies on the role of cuproptosis regulating immune infiltration in AAA. We extracted a published GEO dataset (GSE57691), with 49 AAA and 10 control transcriptome sequencing samples. Then, we analyzed the difference of cuproptosis related genes (CRGs) expression between AAA and normal groups. LIPT1, FDX1 and CDKN2A were upregulated in AAA samples (P < 0.05). Subsequently, we analyzed the difference of immune infiltrate cells between the AAA and normal samples. Compared to the normal group, Dendritic cells, Mast activated cells, Monocytes, M0 macrophages, neutrophils, Plasma cells, CD4-naive T cells, follicular-helper T cells and Treg cells were upregulated in the AAA group, while M1 and M2 macrophages, CD4-memory T cells and gamma delta T cells were downregulated. AAA samples were then classified into two subtypes according to the expression profiles of CRGs, the immunological characteristics and function had significant differences between subtypes. Furthermore, we mined 20 hub genes by using Weighted Gene Co-expression Network Analysis (WGCNA) to construct a co-expression network. Three drugs were identified that interacting with eight hub genes based on the gene-drug interaction database. We finally verified the mRNA differences of the CRGs in the aorta of AAA and healthy mice in vitro. LIPT1, CDKN2A and FDX1 may play a role in regulating the development of AAA through immune infiltration. Eight NDUF subunits, including NDUFA1, NDUFA4, and NDUFB1, may also play an important role in this process. In addition, Metformin, ME-344 and NV-128 may be therapeutic agents for AAA by regulating the cuproptosis.
- 21 January 2025
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 87 (3) , 1282-1294
Open AccessComprehensive analysis the role of cuproptosis related genes in abdominal aortic aneurysm
Immune infiltration plays an important role in the course of abdominal aortic aneurysm (AAA) development, and copper death (cuproptosis) is a new type of programmed cell death recently discovered. Currently, there are no studies on the role of cuproptosis regulating immune infiltration in AAA. We extracted a published GEO dataset (GSE57691), with 49 AAA and 10 control transcriptome sequencing samples. Then, we analyzed the difference of cuproptosis related genes (CRGs) expression between AAA and normal groups. LIPT1, FDX1 and CDKN2A were upregulated in AAA samples (P < 0.05). Subsequently, we analyzed the difference of immune infiltrate cells between the AAA and normal samples. Compared to the normal group, Dendritic cells, Mast activated cells, Monocytes, M0 macrophages, neutrophils, Plasma cells, CD4-naive T cells, follicular-helper T cells and Treg cells were upregulated in the AAA group, while M1 and M2 macrophages, CD4-memory T cells and gamma delta T cells were downregulated. AAA samples were then classified into two subtypes according to the expression profiles of CRGs, the immunological characteristics and function had significant differences between subtypes. Furthermore, we mined 20 hub genes by using Weighted Gene Co-expression Network Analysis (WGCNA) to construct a co-expression network. Three drugs were identified that interacting with eight hub genes based on the gene-drug interaction database. We finally verified the mRNA differences of the CRGs in the aorta of AAA and healthy mice in vitro. LIPT1, CDKN2A and FDX1 may play a role in regulating the development of AAA through immune infiltration. Eight NDUF subunits, including NDUFA1, NDUFA4, and NDUFB1, may also play an important role in this process. In addition, Metformin, ME-344 and NV-128 may be therapeutic agents for AAA by regulating the cuproptosis.
- 20 January 2025
- Published by Wiley in The FASEB Journal
- Vol. 39 (2) , e70318
TRAF6 promotes abdominal aortic aneurysm development by activating macrophage pyroptosis via the NLRP3 /Caspase1/ GSDMD pathway
Abdominal aortic aneurysm represents a critical pathology of the aorta that currently lacks effective pharmacological interventions. TNF receptor‐associated factor 6 (TRAF6) has been established to be involved in cardiovascular diseases such as atherosclerosis, hypertension, and heart failure. However, its role in abdominal aortic aneurysm (AAA) remains unclear. This study aimed to explore the role of TRAF6 on AAA formation and its underlying mechanisms. Single‐cell RNA sequencing of human AAA tissues demonstrated that TRAF6 was significantly upregulated in aortic macrophages. Moreover, overexpression of TRAF6 promotes AAA formation in elastase‐induced C57BL/6 mice, while TRAF6 pharmacological inhibition could attenuate AAA development. Consistently, inhibition of TRAF6 in macrophages through in vitro methods notably limits their pyroptosis, while also diminishing proinflammatory responses in these cells. Mechanistically, TRAF6 can modulate macrophage pyroptosis through the NLRP3/Caspase1/GSDMD signaling pathway. Our study highlights the crucial role of the TRAF6/NLRP3/Caspase1/GSDMD axis in macrophage pyroptosis and AAA, offering potential biomarkers and therapeutic targets for AAA.
- 20 January 2025
- Published by Wiley in The FASEB Journal
- Vol. 39 (2) , e70318
TRAF6 promotes abdominal aortic aneurysm development by activating macrophage pyroptosis via the NLRP3 /Caspase1/ GSDMD pathway
Abdominal aortic aneurysm represents a critical pathology of the aorta that currently lacks effective pharmacological interventions. TNF receptor‐associated factor 6 (TRAF6) has been established to be involved in cardiovascular diseases such as atherosclerosis, hypertension, and heart failure. However, its role in abdominal aortic aneurysm (AAA) remains unclear. This study aimed to explore the role of TRAF6 on AAA formation and its underlying mechanisms. Single‐cell RNA sequencing of human AAA tissues demonstrated that TRAF6 was significantly upregulated in aortic macrophages. Moreover, overexpression of TRAF6 promotes AAA formation in elastase‐induced C57BL/6 mice, while TRAF6 pharmacological inhibition could attenuate AAA development. Consistently, inhibition of TRAF6 in macrophages through in vitro methods notably limits their pyroptosis, while also diminishing proinflammatory responses in these cells. Mechanistically, TRAF6 can modulate macrophage pyroptosis through the NLRP3/Caspase1/GSDMD signaling pathway. Our study highlights the crucial role of the TRAF6/NLRP3/Caspase1/GSDMD axis in macrophage pyroptosis and AAA, offering potential biomarkers and therapeutic targets for AAA.
- Open Access
- 28 June 2024
- Published by Frontiers Media SA in Frontiers in Neurology
- Vol. 15, 1346408
Non-linear relationship between red blood cell distribution width and gastrointestinal bleeding risk in stroke patients: results from multi-center ICUs
Background: The red blood cell distribution width (RDW) is closely linked to the prognosis of multiple diseases. However, the connection between RDW and gastrointestinal bleeding (GIB) in stroke patients is not well understood. This study aimed to clarify this association.Methods: This retrospective study involved 11,107 hospitalized patients from 208 hospitals in the United States, admitted between January 1, 2014, and December 31, 2015. We examined clinical data from 7,512 stroke patients in the intensive care unit (ICU). Multivariate logistic regression assessed the link between RDW and in-hospital GIB in stroke patients. Generalized additive model (GAM) and smooth curve fitting (penalty spline method) were utilized to explore the non-linear relationship between RDW and GIB in stroke patients. The inflection point was calculated using a recursive algorithm, and interactions between different variables were assessed through subgroup analyses.Results: Among the 11,107 screened stroke patients, 7,512 were included in the primary analysis, with 190 identified as having GIB. The participants had a mean age of (61.67 ± 12.42) years, and a median RDW of 13.9%. Multiple logistic analysis revealed RDW as a risk factor for in-hospital GIB in stroke patients (OR = 1.28, 95% CI 1.21, 1.36, p < 0.05). The relationship between RDW and in-hospital GIB in stroke patients was found to be non-linear. Additionally, the inflection point of RDW was 14.0%. When RDW was ≥14.0%, there was a positive association with the risk of GIB (OR: 1.24, 95% CI: 1.16, 1.33, p < 0.0001). Conversely, when RDW was p = 0.4040).Conclusion: This study showed a substantial non-linear link between RDW and the risk of GIB in stroke patients. Maintaining the patient’s RDW value below 14.0% could lower the risk of in-hospital GIB.
- 28 June 2024
- Published by Frontiers Media SA in Frontiers in Neurology
- Vol. 15, 1346408
Open AccessNon-linear relationship between red blood cell distribution width and gastrointestinal bleeding risk in stroke patients: results from multi-center ICUs
Background: The red blood cell distribution width (RDW) is closely linked to the prognosis of multiple diseases. However, the connection between RDW and gastrointestinal bleeding (GIB) in stroke patients is not well understood. This study aimed to clarify this association.Methods: This retrospective study involved 11,107 hospitalized patients from 208 hospitals in the United States, admitted between January 1, 2014, and December 31, 2015. We examined clinical data from 7,512 stroke patients in the intensive care unit (ICU). Multivariate logistic regression assessed the link between RDW and in-hospital GIB in stroke patients. Generalized additive model (GAM) and smooth curve fitting (penalty spline method) were utilized to explore the non-linear relationship between RDW and GIB in stroke patients. The inflection point was calculated using a recursive algorithm, and interactions between different variables were assessed through subgroup analyses.Results: Among the 11,107 screened stroke patients, 7,512 were included in the primary analysis, with 190 identified as having GIB. The participants had a mean age of (61.67 ± 12.42) years, and a median RDW of 13.9%. Multiple logistic analysis revealed RDW as a risk factor for in-hospital GIB in stroke patients (OR = 1.28, 95% CI 1.21, 1.36, p < 0.05). The relationship between RDW and in-hospital GIB in stroke patients was found to be non-linear. Additionally, the inflection point of RDW was 14.0%. When RDW was ≥14.0%, there was a positive association with the risk of GIB (OR: 1.24, 95% CI: 1.16, 1.33, p < 0.0001). Conversely, when RDW was p = 0.4040).Conclusion: This study showed a substantial non-linear link between RDW and the risk of GIB in stroke patients. Maintaining the patient’s RDW value below 14.0% could lower the risk of in-hospital GIB.
- 22 June 2024
- Published by Wiley in The FASEB Journal
- Vol. 38 (13) , e23707
Single‐cell RNA sequencing reveals that NRF2 regulates vascular smooth muscle cell phenotypic switching in abdominal aortic aneurysm
Abdominal aortic aneurysm (AAA) is a life‐threatening disease characterized by extensive membrane destruction in the vascular wall that is closely associated with vascular smooth muscle cell (VSMC) phenotypic switching. A thorough understanding of the changes in regulatory factors during VSMC phenotypic switching is essential for managing AAA therapy. In this study, we revealed the impact of NRF2 on the modulation of VSMC phenotype and the development of AAA based on single‐cell RNA sequencing analysis. By utilizing a murine model of VSMC‐specific knockout of nuclear factor E2‐related factor 2 (NRF2), we observed that the absence of NRF2 in VSMCs exacerbated AAA formation in an angiotensin II‐induced AAA model. The downregulation of NRF2 promoted VSMC phenotypic switching, leading to an enhanced inflammatory response. Through genome‐wide transcriptome analysis and loss‐ or gain‐of‐function experiments, we discovered that NRF2 upregulated the expression of VSMC contractile phenotype‐specific genes by facilitating microRNA‐145 (miR‐145) expression. Our data identified NRF2 as a novel regulator involved in maintaining the VSMC contractile phenotype while also influencing AAA formation through an miR‐145‐dependent regulatory mechanism.
- 22 June 2024
- Published by Wiley in The FASEB Journal
- Vol. 38 (13) , e23707
Single‐cell RNA sequencing reveals that NRF2 regulates vascular smooth muscle cell phenotypic switching in abdominal aortic aneurysm
Abdominal aortic aneurysm (AAA) is a life‐threatening disease characterized by extensive membrane destruction in the vascular wall that is closely associated with vascular smooth muscle cell (VSMC) phenotypic switching. A thorough understanding of the changes in regulatory factors during VSMC phenotypic switching is essential for managing AAA therapy. In this study, we revealed the impact of NRF2 on the modulation of VSMC phenotype and the development of AAA based on single‐cell RNA sequencing analysis. By utilizing a murine model of VSMC‐specific knockout of nuclear factor E2‐related factor 2 (NRF2), we observed that the absence of NRF2 in VSMCs exacerbated AAA formation in an angiotensin II‐induced AAA model. The downregulation of NRF2 promoted VSMC phenotypic switching, leading to an enhanced inflammatory response. Through genome‐wide transcriptome analysis and loss‐ or gain‐of‐function experiments, we discovered that NRF2 upregulated the expression of VSMC contractile phenotype‐specific genes by facilitating microRNA‐145 (miR‐145) expression. Our data identified NRF2 as a novel regulator involved in maintaining the VSMC contractile phenotype while also influencing AAA formation through an miR‐145‐dependent regulatory mechanism.
- Open Access
- 28 September 2022
- Published by Wiley in Cardiology Research and Practice
- Vol. 2022, 1-6
Flow-Mediated Dilatation in the Assessment of Coronary Heart Disease: A Meta-Analysis
Endothelial dysfunction may contribute to the increased morbidity and mortality associated with coronary heart disease (CHD). Flow-mediated dilatation (FMD) is the most popular noninvasive method for vascular endothelial function evaluation. This meta-analysis aimed to investigate the association between FMD and CHD. We searched the publications listed in the PubMed, Web of Science, Scopus, and Embase databases. Stata 14 software was used to analyze the data. Standardized mean difference (SMD) was used to calculate FMD levels, and the effect sizes were expressed with a 95% confidence interval (CI). I2 statistics were used to evaluate statistical heterogeneity. In this meta-analysis, 9 studies enrolled a total number of 943 participants, including 534 (56.63%) patients with CHD and 409 controls (43.37%). We found that patients with CHD showed a significantly lower FMD than the controls (SMD −0.706%; 95% CI: −0.985, −0.427; ) with high heterogeneity. In addition, funnel plot analysis suggested asymmetry that could be evidence of publication bias. But sensitivity analyses show that there were no influential studies. This meta-analysis provides evidence that patients with CHD show a significantly lower FMD than controls and highlights the literature on FMD as a hallmark in CHD diseases.
- 28 September 2022
- Published by Wiley in Cardiology Research and Practice
- Vol. 2022, 1-6
Open AccessFlow-Mediated Dilatation in the Assessment of Coronary Heart Disease: A Meta-Analysis
Endothelial dysfunction may contribute to the increased morbidity and mortality associated with coronary heart disease (CHD). Flow-mediated dilatation (FMD) is the most popular noninvasive method for vascular endothelial function evaluation. This meta-analysis aimed to investigate the association between FMD and CHD. We searched the publications listed in the PubMed, Web of Science, Scopus, and Embase databases. Stata 14 software was used to analyze the data. Standardized mean difference (SMD) was used to calculate FMD levels, and the effect sizes were expressed with a 95% confidence interval (CI). I2 statistics were used to evaluate statistical heterogeneity. In this meta-analysis, 9 studies enrolled a total number of 943 participants, including 534 (56.63%) patients with CHD and 409 controls (43.37%). We found that patients with CHD showed a significantly lower FMD than the controls (SMD −0.706%; 95% CI: −0.985, −0.427; ) with high heterogeneity. In addition, funnel plot analysis suggested asymmetry that could be evidence of publication bias. But sensitivity analyses show that there were no influential studies. This meta-analysis provides evidence that patients with CHD show a significantly lower FMD than controls and highlights the literature on FMD as a hallmark in CHD diseases.